Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday 3rd February 2025 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and nine months ended on 31st December 2024. 2.) The board has considered and accepted the resignation of Independent Director Mr Niraj Vaghela w e.f 03.02.2025. 3.) Mr. Kelash Bunkar is appointed as non-executive independent director of the company w e f. 03.02.2025 subject to approval of members in AGM. The board meeting commenced at 05:40 PM and concluded at 06:00 PM Please take the above intimation in your records.

pdf

Amerise Biosciences Ltd.

22 Jan 2025

0.91

-2.15%

Board Meeting

Amerise Biosciences Ltd - 531681 - Board Meeting Intimation for Compliance Of Regulation 29 And Reg …

BSE India

Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 ,inter alia, to consider and approve Pursuantto Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday 3rd February 2025 inter alia, to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2024. 2.) To approve and consider the appointment of Mr. Kelash Bunkar as Director of the Company. 3.) To consider the resignation of Mr. Niraj Vaghela from directorship of the Company. 4.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.

pdf